Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy
J Nucl Med
.
2023 Mar;64(3):347-348.
doi: 10.2967/jnumed.122.264900.
Epub 2022 Dec 22.
Authors
Kelsey L Pomykala
1
,
Marcus Würker
2
,
Ken Herrmann
3
Affiliations
1
Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany; kelsey.herrmann@uk-essen.de.
2
Deutsche Post DHL Group, Bonn, Germany; and.
3
Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium-University Hospital Essen, Essen, Germany.
PMID:
36549917
PMCID:
PMC10071808
DOI:
10.2967/jnumed.122.264900
No abstract available